IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. (Q27851563)

PubMed

PubMed publication ID

20445578

13 November 2016

title

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. (English)

1 reference

PubMed

PubMed publication ID

13 November 2016

R P Kuiper

1

0 references

E Waanders

2

0 references

V H J van der Velden

3

0 references

S V van Reijmersdal

4

0 references

R Venkatachalam

5

0 references

B Scheijen

6

0 references

E Sonneveld

7

0 references

J J M van Dongen

8

0 references

A J P Veerman

9

0 references

F N van Leeuwen

10

0 references

A Geurts van Kessel

11

0 references

P M Hoogerbrugge

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray

12

0 references

publication date

July 2010

0 references

published in

Leukemia

0 references

volume

24

0 references

issue

7

0 references

page(s)

1258-64

0 references

cites work

1 reference

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

21 April 2017

1 reference

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

21 April 2017

1 reference

Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: a platform comparison based on statistical power analysis

21 April 2017

1 reference

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

21 April 2017

1 reference

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

21 April 2017

1 reference

Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.

21 April 2017

1 reference

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

21 January 2018

1 reference

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.

21 January 2018

1 reference

Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development

21 January 2018

1 reference

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

21 January 2018

1 reference

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.

21 January 2018

1 reference

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute

21 January 2018

1 reference

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).

21 January 2018

1 reference

A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays

21 January 2018

1 reference

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.

21 January 2018

1 reference

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv

21 January 2018

1 reference

Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia

21 January 2018

1 reference

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

21 January 2018

1 reference

Acute lymphoblastic leukemia

21 January 2018

1 reference

7 January 2021

Detailed clonality analysis of relapsing precursor B acute lymphoblastic leukemia: implications for minimal residual disease detection

1 reference

7 January 2021

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone

1 reference

7 January 2021

Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14

1 reference

7 January 2021

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

7 January 2021

Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of secon

1 reference

7 January 2021

JAK mutations in high-risk childhood acute lymphoblastic leukemia

1 reference

7 January 2021